Emerging treatments

Melatonergic agents

A case report suggests that the melatonergic agents agomelatine and extended-release melatonin can aid in relieving sleep-related eating disorder.[92]​ Extended-release melatonin has been studied for the treatment of rapid eye movement sleep behaviour disorder (RBD). While findings are conflicting, a 'chronobiotic' protocol of low-dose extended-release melatonin given at the same time nightly improved RBD symptoms even several months after treatment discontinuation.[93]

Use of this content is subject to our disclaimer